PRFXPAINREFORM LTD.

Nasdaq painreform.com


$ 0.28 $ -0.05 (-15.2 %)    

Tuesday, 20-Aug-2024 15:54:06 EDT
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 0.2633
$ 0.27 x 100
$ 0.32 x 3,200
-- - --
$ 0.24 - $ 5.15
37,708,670
na
344,639
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 painreform-announces-development-and-manufacturing-of-new-formulations-providing-anti-inflammatory-and-extended-analgesic-effects

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

 painreform-announces-prf-110-promoted-normal-wound-healing-and-prevented-scar-formation-following-surgical-procedures-on-track-to-report-top-line-results-from-the-phase-3-trial-in-the-second-half-of-2024

PRF-110 promoted normal wound healing and prevented scar formation following surgical procedures Company reaffirms it is on tra...

 painreforms-new-manufacturing-process-achieves-18-month-stability-of-prf-110-at-room-temperature

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

 on-june-24-painreform-ilan-hadar-ceo--cfo-ceased-his-service-to-co-appointed-ehud-geller-as-interim-ceo--cfo

- SEC Filing

 maxim-group-reiterates-buy-on-painreform-maintains-2-price-target

Maxim Group analyst Naz Rahman reiterates PainReform (NASDAQ:PRFX) with a Buy and maintains $2 price target.

 painreform-completes-enrollment-in-second-part-of-its-phase-3-bunionectomy-trial-for-prf-110

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

 painreform-ceo-ilan-hadar-discusses-latest-developments-related-to-prf-110-to-help-tackle-the-opioid-epidemic

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 why-ascent-solar-technologies-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced p...

 why-pricesmart-shares-are-trading-higher-by-around-5-here-are-20-stocks-moving-premarket

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expecte...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION